Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Clinical Pharmacology of Miami, Miami, Florida Orlando Clinical Research Center, Orlando, Florida American Research Corporation at Texas Liver Institute, San Antonio, Texas Hungary
CRU Early Phase Unit, Kistarcsa